Curemark Competitors and Similar CompaniesClear all
Curemark's competitors and similar companies include PaxMedica and Synthorx.
 Curemark Curemark is a biopharmaceutical company focused on developing therapies for the treatment of neurological and other disorders. |  PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | |
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Rye, US HQ Rye Brook, US | Locations Tarrytown, US HQ | Locations San Diego, US HQ |
Employees | Employees 23 | Employees 2100% increase | Employees 3939% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 m | Valuation ($) 2.2 b |
Financial | |||
Net income | Net income N/A | Net income ($18.3m) (FY, 2023) | Net income ($5.9m) (FY, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 55.7m | Total funding raised N/A | Total funding raised $ 79m |
For sources of this data, please see the company profile
View Company Profiles
PaxMedica
HQ
Tarrytown, US
Employees
2
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View companySynthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company